CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
Bharat Forge Ltd. 25/07/20241,593.85952.3007/04/2025 -40.25% 256 days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

SPARC grants exclusive license to Tripoint Therapeutics to commercialise Epilepsy tablets in USA

DSIJ Intelligence 0 849 Article rating: 5.0

Sun Pharma Advanced Research Company Ltd (SPARC) today announced the grant of an exclusive license to Tripoint Therapeutics LLC, USA (Tripoint) to commercialise ElepsiaTM XR 1,000 mg and ElepsiaTM XR 1,500 mg tablets in the USA.

GMM Pfaudler announces offer for sale at Rs 3,500; shares hit lower circuit, plunge 10 per cent

Pratik Shastri 0 2624 Article rating: 2.9

Now, what is so worrisome to investors in GMM? The major concern is the size of the stake available to sell. As per the press release by the company, the equity shares representing 17.59 per cent are being offered in the prevailing OFS.

National Fertilizers near four-year low on BSE despite double-digit sales growth

Nidhi Jani 0 1097 Article rating: 4.3

Despite the sales & volume growth, the price realisations and delay in the payment of subsidy remain as the key challenges to the company. Further, the lack of availability of domestic gas to fertiliser sector and increasing trend in the price of spot RLNG, volatile prices of fertilisers in the international market add vows to the company.

Sensex & Nifty bleed, banks tumble; Tata Consumer dips by 7 per cent, BEL plunges 8 per cent

DSIJ Intelligence 0 1551 Article rating: 4.3

Starting the expiry week of the September, the domestic markets were volatile on Monday. Later during the day, the indices plunged, owing to the global sell-off cues as well as due to FinCEN’s announcement. Sensex slid by 811.68 points or 2.09 per cent to close at 38,034.14 while Nifty declined by 283.25 points or 2.46 per cent to settle at 11,221.70.

Sensex, Nifty erase gains; Natco Pharma zooms by 14 per cent, Dr Reddys at all-time high

DSIJ Intelligence 0 902 Article rating: 4.5

Dragged mainly by banking and financial stocks, the domestic benchmark indices on Friday, witnessed a sharp fall during the afternoon session. Sensex fell by more than 300 points from the day’s high to close at 38,845.82 levels, down by 134.03 points or 0.34 per cent from its previous close. Nifty declined by 11.15 points or 0.10 per cent to settle at 11,504.95 levels.

Slippery Sensex close below 39,000; Dr Reddy's Lab becomes top Nifty gainer, Mphasis makes new lifetime high

DSIJ Intelligence 0 805 Article rating: 5.0

Markets were slippery throughout the session on Thursday. Sensex tanked 323 points or 0.82 per cent to close at 38,979.75 levels. Nifty was down by 85.30 points or 0.74 per cent to close at 11,519.25 levels. 

Ashok Leyland bags order from logistics startup to supply 1,400 trucks

DSIJ Intelligence 0 1953 Article rating: 4.3

The flagship company of Hinduja Group, Ashok Leyland, announced on Thursday that it has received a large order from a logistics start-up company, Procure Box. The order is for 1,400 intermediate commercial vehicles (ICVs) for its fuel distribution business across 750 districts in the country.

Dr Reddy's Laboratories forays into OTC eye-care space; stock up by 3 per cent

DSIJ Intelligence 0 747 Article rating: 5.0

Dr Reddy’s Laboratories, along with its subsidiaries, announced the launch of over-the-counter (OTC) Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2 per cent and 0.1 per cent, on Thursday. The store brand is equivalent to Pataday Once Daily Relief and Pataday Twice Daily Relief in the US market.

Sensex, Nifty extend gains; Man Industries jumps by 17 per cent, Dr Reddys gains post COVID-19 vaccine news

DSIJ Intelligence 0 1749 Article rating: 4.0

On Wednesday, the domestic markets witnessed a volatile session after the benchmark indices gained during the afternoon session. Sensex rose by 258.50 points or 0.66 per cent to close at 39,302.85 while Nifty gained by 76.90 points or 0.67 per cent to settle at 11,598.70.

Lakshmi Vilas Bank hits 10 per cent upper circuit on Clix Group merger development

DSIJ Intelligence 0 1742 Article rating: 4.3

The shares of Lakshmi Vilas Bank jumped by 10 per cent intraday thereby, hitting its upper circuit of 10 per cent on Wednesday after the bank said that the due diligence process for its merger with Clix Group is substantially complete and both parties are now in discussions regarding the next step.

RSS
First330331332333335337338339Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR